Medicine and Dentistry
Breast Cancer
100%
BRCA1
63%
Malignant Neoplasm
42%
Ovarian Cancer
35%
Triple Negative Breast Cancer
24%
Biological Marker
20%
Prostate Cancer
18%
Axilla
18%
Metastatic Colorectal Cancer
18%
Colorectal Cancer
17%
Cancer Risk
14%
Neoadjuvant Chemotherapy
14%
BRCA2
12%
Disease
12%
Nodal Metastasis
12%
Cohort Effect
12%
Needle Biopsy
12%
Preoperative Systemic Therapy
12%
Fine-Needle Aspiration
12%
Cancer Syndrome
12%
Diagnosis
10%
Endometrial Cancer
10%
Mastectomy
10%
Penetrance
9%
Neoplasm
9%
Body Mass Index
9%
microRNA
9%
Survival Rate
9%
APC
9%
Gene Mutation
8%
Epidermal Growth Factor Receptor
8%
Familial Adenomatous Polyposis
8%
Breast Reconstruction
8%
Cancer Susceptibility
8%
Recurrent Disease
8%
Prognostic Factor
7%
Progression Free Survival
7%
Genetic Screening
7%
microRNA 31
7%
Combination Therapy
7%
Overall Survival
7%
Disease Specific Survival
7%
Personalized Medicine
6%
Trastuzumab
6%
Cancer Specific Survival
6%
Surgery
6%
Hypoxia
6%
Pervasive Developmental Disorder
6%
Infection
6%
Gut Microbiota
6%
Anemia
6%
Dysbiosis
6%
Aeromonas
6%
Differentiated Thyroid Cancer
6%
Mass Screening
6%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
6%
Clear Cell Renal Cell Carcinoma
6%
Hepatocellular Carcinoma
6%
Phlebothrombosis
6%
Population Research
6%
Erythrocyte
6%
Checkpoint Kinase 2
6%
microRNA 214
6%
Hereditary Nonpolyposis Colorectal Cancer
6%
Contralateral
6%
Survival Prediction
6%
Genotype Phenotype Correlation
6%
Rectum Cancer
6%
Hamartoma
6%
Staphylococcus Aureus
6%
Clinical Guideline
6%
Lung Adenocarcinoma
6%
Hemorrhoid
6%
Meticillin
6%
Geographic Distribution
6%
Methamidophos
6%
Antioxidant
6%
Allele
6%
Chromothripsis
6%
Chronic Venous Insufficiency
6%
Noonan Syndrome
6%
Immunoglobulin A Nephropathy
6%
Rotavirus
6%
B Cell
6%
Cell Function
6%
Adjuvant Chemotherapy
6%
Recurrence Risk
5%
Salpingooophorectomy
5%
Recurrence Free Survival
5%
Health Service
5%
False Negative Result
5%
Biochemistry, Genetics and Molecular Biology
BRCA1
64%
CHEK2
25%
BRCA2
22%
Germ Cell
20%
Gene Expression
19%
Real-Time Polymerase Chain Reaction
19%
Germline
18%
Cancer Cell
18%
Cohort Study
13%
Germline Mutation
13%
Genetic Screening
12%
MSH6
10%
Next Generation Sequencing
10%
Proband
9%
Genotyping
9%
Single-Nucleotide Polymorphism
9%
MSH2
8%
Gene Mutation
8%
Genetic Risk
8%
Allele
8%
Missense Mutation
7%
Penetrance
7%
Sanger Sequencing
7%
NOD2
6%
Neovascularization (Pathology)
6%
Transcriptomics
6%
Methicillin Susceptible Staphylococcus Aureus
6%
Genome Instability
6%
Coding Region
6%
Survival Prediction
6%
Progression Free Survival
6%
Chromothripsis
6%
Protein-Protein Interaction
6%
Phlebothrombosis
6%
Medical Genomics
6%
Cell Culture
6%
Brassinosteroid
6%
Cancer Screening
6%
Population
6%
Electric Power Plant
6%
Genotype Phenotype Correlation
6%
Intron
6%
Haplotype
6%
Anabolism
6%
Recurrence Free Survival
6%
MLH1
5%
MRE11A
5%
Overall Survival
5%
Prevalence
5%
Cancer Specific Survival
5%
Chloroplast
5%
Gene Expression Profiling
5%